Adimab
Nathan Sharkey has worked in the scientific field since 2006. Nathan began their career at Merck, where they were an Associate Principal Scientist from 2006 to 2015. Nathan then moved to Adimab, LLC, where they held the roles of Scientist, Associate Scientist, and PRA from 2015 to present.
Nathan Sharkey attended the University of New Hampshire from 1999 to 2003, where they earned a Bachelor's Degree in Chemical Engineering.
Adimab
1 followers
Adimab is an antibody discovery and optimization platform, developing full-length human Immunoglobulin Gs.